While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis hasn't changed. Novo Nordisk is still a dominant player in a growing industry, ...

For older adults with obesity, neither weighted vest use nor resistance training (RT) mitigates weight loss (WL)-associated ...

Uterine cancer incidence and mortality rates are projected to increase significantly over the next three decades in the United States, with incidence-based mortality expected to be nearly three times ...

The ultra-low calorie ketogenic approach shows promising results for obesity but comes with significant health risks many ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

The Trump administration's decision to fire the CDC team whose job it was to provide clinical guidelines on how to safely ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

Childhood obesity rates continue to soar in the U.S. A new study finds obesity in children and teens increased significantly between 2011 and 2023. And research ...

Incidence and mortality rates for uterine cancer are projected to rise substantially over the next 3 decades, according to ...

Caregivers for people with dementia are more likely to report having at least one modifiable risk factor linked to developing dementia.

(HealthDay News) — For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine Disability Assessment (MIDAS) scores, according ...